In the well‐studied breast cancer patient cohort GSE 19783‐GPL6580 representing all subtypes (Enerly et al,2011), high TNC levels (above the median) and combined high TNC and high CD8 TIL correlated with shorter overall survival (Fig 7H and I, Appendix Fig S5L). The gene discussed is CD8A; the disease is breast cancer.